1. Home
  2. WW vs AVTE Comparison

WW vs AVTE Comparison

Compare WW & AVTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WW
  • AVTE
  • Stock Information
  • Founded
  • WW 1961
  • AVTE 2018
  • Country
  • WW United States
  • AVTE United States
  • Employees
  • WW N/A
  • AVTE N/A
  • Industry
  • WW Other Consumer Services
  • AVTE Biotechnology: Pharmaceutical Preparations
  • Sector
  • WW Consumer Discretionary
  • AVTE Health Care
  • Exchange
  • WW Nasdaq
  • AVTE Nasdaq
  • Market Cap
  • WW 75.9M
  • AVTE 68.7M
  • IPO Year
  • WW 2001
  • AVTE 2021
  • Fundamental
  • Price
  • WW $0.72
  • AVTE $2.37
  • Analyst Decision
  • WW Buy
  • AVTE Hold
  • Analyst Count
  • WW 4
  • AVTE 7
  • Target Price
  • WW $3.44
  • AVTE $11.75
  • AVG Volume (30 Days)
  • WW 2.3M
  • AVTE 135.0K
  • Earning Date
  • WW 03-03-2025
  • AVTE 03-24-2025
  • Dividend Yield
  • WW N/A
  • AVTE N/A
  • EPS Growth
  • WW N/A
  • AVTE N/A
  • EPS
  • WW N/A
  • AVTE N/A
  • Revenue
  • WW $807,465,000.00
  • AVTE N/A
  • Revenue This Year
  • WW N/A
  • AVTE N/A
  • Revenue Next Year
  • WW N/A
  • AVTE N/A
  • P/E Ratio
  • WW N/A
  • AVTE N/A
  • Revenue Growth
  • WW N/A
  • AVTE N/A
  • 52 Week Low
  • WW $0.67
  • AVTE $1.25
  • 52 Week High
  • WW $3.92
  • AVTE $32.42
  • Technical
  • Relative Strength Index (RSI)
  • WW 27.59
  • AVTE 37.24
  • Support Level
  • WW $0.77
  • AVTE $2.35
  • Resistance Level
  • WW $0.94
  • AVTE $2.49
  • Average True Range (ATR)
  • WW 0.08
  • AVTE 0.10
  • MACD
  • WW -0.01
  • AVTE -0.01
  • Stochastic Oscillator
  • WW 1.53
  • AVTE 11.43

About WW WW International Inc.

WW International Inc is a provider of weight loss solutions. The firm offers its members access to in person workshops and digital solutions as a part of its weight loss and weight management programs. Its digital app provides members access to tools such as, trackers for food, water, activity, weight, content regarding behavioral techniques for building healthy habits and other related tools. Along with its in person workshops and digital solutions, the company also provides members who medically qualify access to clinicians who can prescribe weight management medications when clinically appropriate. The company generates majority of its revenue in the form of Subscription Revenue. Geographically, the company generates key revenue from North America and rest from International markets.

About AVTE Aerovate Therapeutics Inc.

Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. The initial focus of the company is on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.

Share on Social Networks: